Veracity Capital
REGN icon

Veracity Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Veracity Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.18M Sell
5,510
-46
-0.8% -$34.8K 1.12% 14
2026
Q2 		$3.46M Buy
5,556
+3
+0.1% +$2.04K 0.94% 16
2026
Q1 		$4.29M Sell
5,553
-73
-1% -$55.9K 1.53% 9
2025
Q4 		$4.34M Buy
5,626
+4
+0.1% +$2.72K 1.28% 11
2025
Q3 		$3.16M Buy
5,622
+25
+0.4% +$14.1K 1.01% 10
2025
Q2 		$2.94M Sell
5,597
-4
-0.1% -$2.23K 1.01% 11
2025
Q1 		$3.55M Sell
5,601
-13
-0.2% -$8.94K 1.38% 8
2024
Q4 		$4M Sell
5,614
-58
-1% -$48.7K 1.44% 9
2024
Q3 		$5.96M Sell
5,672
-140
-2% -$156K 2.26% 7
2024
Q2 		$6.11M Sell
5,812
-310
-5% -$301K 2.54% 6
2024
Q1 		$5.89M Sell
6,122
-241
-4% -$229K 2.29% 7
2023
Q4 		$5.59M Sell
6,363
-104
-2% -$85.6K 2.24% 7
2023
Q3 		$5.32M Sell
6,467
-51
-0.8% -$40.1K 2.47% 5
2023
Q2 		$4.68M Buy
6,518
+17
+0.3% +$13.1K 1.99% 7
2023
Q1 		$5.34M Sell
6,501
-293
-4% -$221K 2.47% 7
2022
Q4 		$4.9M Sell
6,794
-145
-2% -$107K 2.35% 5
2022
Q3 		$4.78M Buy
6,939
+2
+0% +$1.26K 2.6% 6
2022
Q2 		$4.1M Sell
6,937
-110
-2% -$71.5K 2.18% 7
2022
Q1 		$4.92M Sell
7,047
-221
-3% -$140K 2.04% 7
2021
Q4 		$4.59M Buy
7,268
+37
+0.5% +$22.7K 1.84% 10
2021
Q3 		$4.38M Sell
7,231
-530
-7% -$329K 1.88% 8
2021
Q2 		$4.34M Sell
7,761
-124
-2% -$62.8K 1.01% 19
2021
Q1 		$3.73M Sell
7,885
-703
-8% -$342K 1.71% 9
2020
Q4 		$4.15M Buy
8,588
+396
+5% +$214K 2.15% 7
2020
Q3 		$4.59M Buy
8,192
+161
+2% +$97.6K 2.57% 4
2020
Q2 		$5.01M Sell
8,031
-8,205
-51% -$4.66M 2.89% 6
2020
Q1 		$7.93M Sell
16,236
-1,086
-6% -$448K 2.29% 12
2019
Q4 		$6.5M Buy
+17,322
New +$5.83M 1.68% 11

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Loring Wolcott & Coolidge Fiduciary Advisors
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return
LMCG Investments
LMCG Investments Boston, Massachusetts $1.86B AUM 40.01% 1-Year Est. Return

Veracity Capital's REGN Position: Q3 2026 in Review

Veracity Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 0.83% in Q3 2026, selling an estimated $34.8K and leaving 5,510 shares worth $4.18M. The position accounts for 1.12% of the portfolio, ranked #14.

Veracity Capital first reported a position in REGN in Q4 2019 and has held it in 28 quarters since. The position peaked at $7.93M in Q1 2020. 331 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Veracity Capital held 5,510 shares of Regeneron Pharmaceuticals worth $4.18M as of Q3 2026.
  • Veracity Capital sold 46 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $34.8K.
  • Regeneron Pharmaceuticals made up 1.12% of Veracity Capital's portfolio in Q3 2026, its #14 holding.
  • Veracity Capital first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 28 quarters since.
  • Veracity Capital's Regeneron Pharmaceuticals position peaked at $7.93M in Q1 2020.
  • 331 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Veracity Capital's 13F filing for Q3 2026, filed 8 Oct 2026.